Advertisement
Screener

Applied Therapeutics, Inc. Financing Cash Flow

Applied Therapeutics, Inc. Financing Cash Flow

Applied Therapeutics, Inc. reported Financing Cash Flow of -$75.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-13

  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$75.00K.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $0.00.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $113.81M, a 52.67% increase from fiscal 2023.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $74.54M, a 169.18% increase from fiscal 2022.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $27.69M, a 62.94% decline from fiscal 2021.
  • Applied Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $74.72M, a 45.18% decline from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2025-09-30-$75.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$75.00K
derived: sum of 2 quarters · filed 2025-11-13
-$75.00K
10-Q · filed 2025-11-13
-$75.00K
derived: sum of 4 quarters · filed 2025-11-13
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$0.00
10-Q · filed 2025-08-13
$0.00
derived: sum of 3 quarters · filed 2025-08-13
$0.00
derived: sum of 4 quarters · filed 2025-11-13
2025-03-31$0.00
10-Q · filed 2025-05-14
$0.00
derived: sum of 2 quarters · filed 2025-05-14
$0.00
derived: sum of 3 quarters · filed 2025-11-13
-$1.69M
derived: sum of 4 quarters · filed 2025-11-13
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
$0.00
derived: sum of 2 quarters · filed 2025-11-13
-$1.69M
derived: sum of 3 quarters · filed 2025-11-13
$113.81M
10-K · filed 2025-04-15
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$1.69M
derived: sum of 2 quarters · filed 2025-11-13
$113.81M
10-Q · filed 2025-11-13
$143.25M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$1.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$113.81M
10-Q · filed 2025-08-13
$143.25M
derived: sum of 3 quarters · filed 2025-08-13
$159.82M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$115.50M
10-Q · filed 2025-05-14
$144.94M
derived: sum of 2 quarters · filed 2025-05-14
$161.51M
derived: sum of 3 quarters · filed 2025-05-14
$190.66M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$29.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
$46.01M
derived: sum of 2 quarters · filed 2025-04-15
$75.16M
derived: sum of 3 quarters · filed 2025-04-15
$74.54M
10-K · filed 2025-04-15
2023-09-30$16.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$45.72M
derived: sum of 2 quarters · filed 2024-11-07
$45.10M
10-Q · filed 2024-11-07
$44.16M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$29.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$28.53M
10-Q · filed 2024-08-07
$27.60M
derived: sum of 3 quarters · filed 2024-08-07
$26.63M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$622.00K
10-Q · filed 2024-05-09
-$1.55M
derived: sum of 2 quarters · filed 2024-05-09
-$2.53M
derived: sum of 3 quarters · filed 2024-05-09
$27.86M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$933.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$1.90M
derived: sum of 2 quarters · filed 2024-03-06
$28.48M
derived: sum of 3 quarters · filed 2024-03-06
$27.69M
10-K · filed 2024-03-06
2022-09-30-$971.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$29.41M
derived: sum of 2 quarters · filed 2023-11-09
$28.63M
10-Q · filed 2023-11-09
$27.44M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$30.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$29.60M
10-Q · filed 2023-08-10
$28.41M
derived: sum of 3 quarters · filed 2023-08-10
$27.33M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$789.00K
10-Q · filed 2023-05-11
-$1.97M
derived: sum of 2 quarters · filed 2023-05-11
-$3.05M
derived: sum of 3 quarters · filed 2023-05-11
$442.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$2.26M
derived: sum of 2 quarters · filed 2023-03-23
$1.23M
derived: sum of 3 quarters · filed 2023-03-23
$74.72M
10-K · filed 2023-03-23
2021-09-30-$1.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$2.42M
derived: sum of 2 quarters · filed 2022-11-09
$75.90M
10-Q · filed 2022-11-09
$78.99M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$3.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$76.98M
10-Q · filed 2022-08-12
$80.07M
derived: sum of 3 quarters · filed 2022-08-12
$78.84M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$73.49M
10-Q · filed 2022-05-12
$76.58M
derived: sum of 2 quarters · filed 2022-05-12
$75.34M
derived: sum of 3 quarters · filed 2022-05-12
$75.56M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$1.86M
derived: sum of 2 quarters · filed 2022-03-10
$2.08M
derived: sum of 3 quarters · filed 2022-03-10
$136.29M
10-K · filed 2022-03-10
2020-09-30-$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$1.02M
derived: sum of 2 quarters · filed 2021-11-12
$133.20M
10-Q · filed 2021-11-12
$151.52M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$218.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$134.44M
10-Q · filed 2021-08-12
$152.76M
derived: sum of 3 quarters · filed 2021-08-12
$152.46M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$134.22M
10-Q · filed 2021-05-11
$152.54M
derived: sum of 2 quarters · filed 2021-05-11
$152.25M
derived: sum of 3 quarters · filed 2021-05-11
$187.69M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$18.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
$18.03M
derived: sum of 2 quarters · filed 2021-03-18
$53.48M
derived: sum of 3 quarters · filed 2021-03-18
$56.41M
10-K · filed 2021-03-18
2019-09-30-$294.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$35.16M
derived: sum of 2 quarters · filed 2020-11-12
$38.09M
10-Q · filed 2020-11-12
$59.15M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$35.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
$38.39M
10-Q · filed 2020-08-11
$59.45M
derived: sum of 3 quarters · filed 2020-08-11
$59.47M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31$2.94M
10-Q · filed 2020-05-11
$24.00M
derived: sum of 2 quarters · filed 2020-05-11
$24.02M
derived: sum of 3 quarters · filed 2020-05-11
$24.03M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$21.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$21.08M
derived: sum of 2 quarters · filed 2020-03-13
$21.09M
derived: sum of 3 quarters · filed 2020-03-13
$26.65M
10-K · filed 2020-03-13
2018-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$37.00K
derived: sum of 2 quarters · filed 2019-11-13
$5.60M
10-Q · filed 2019-11-13
2018-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
$5.57M
10-Q · filed 2019-08-12
2018-03-31$5.56M
10-Q · filed 2019-06-21